Theradiag SA
EPA:ALTER.PA
1.26 (EUR) • At close December 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.205 | 11.125 | 10.413 | 9.638 | 8.912 | 9.058 | 8.978 | 7.563 | 7.113 | 6.76 | 8.253 | 10.155 |
| Cost of Revenue
| 6.736 | 6.283 | 5.508 | 5.027 | 4.112 | 4.926 | 4.648 | 4.881 | 5.035 | 4.371 | 4.708 | 7.061 |
| Gross Profit
| 5.469 | 4.842 | 4.906 | 4.61 | 4.799 | 4.132 | 4.33 | 2.682 | 2.078 | 2.389 | 3.544 | 3.094 |
| Gross Profit Ratio
| 0.448 | 0.435 | 0.471 | 0.478 | 0.539 | 0.456 | 0.482 | 0.355 | 0.292 | 0.353 | 0.429 | 0.305 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0.458 | 1.431 | 1.416 | 1.482 | 1.522 | 1.157 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.617 | 4.705 | 4.633 | 4.47 | 4.394 | 5.53 | 5.362 | 5.211 | 4.8 | 4.127 | 3.498 | 0 |
| Other Expenses
| 5.747 | 5.721 | 5.502 | 4.514 | 5.362 | 6.647 | 6.555 | 6.093 | 5.271 | -0.01 | 4.523 | 3.684 |
| Operating Expenses
| 5.747 | 5.721 | 5.502 | 4.514 | 5.362 | 6.647 | 6.555 | 6.093 | 5.271 | 4.362 | 4.523 | 3.684 |
| Operating Income
| -0.274 | -0.879 | -0.497 | 0.171 | -0.501 | -2.503 | -2.225 | -3.411 | -3.193 | -1.974 | -0.979 | -0.59 |
| Operating Income Ratio
| -0.022 | -0.079 | -0.048 | 0.018 | -0.056 | -0.276 | -0.248 | -0.451 | -0.449 | -0.292 | -0.119 | -0.058 |
| Total Other Income Expenses Net
| -0.419 | -0.149 | -0.118 | 0.689 | -0.479 | -0.772 | -0.048 | -0.084 | -0.171 | -0.1 | -0.171 | 0.251 |
| Income Before Tax
| -0.693 | -1.028 | -0.615 | 0.067 | -1.042 | -4.791 | -2.272 | -3.495 | -3.364 | -2.074 | -1.15 | -0.339 |
| Income Before Tax Ratio
| -0.057 | -0.092 | -0.059 | 0.007 | -0.117 | -0.529 | -0.253 | -0.462 | -0.473 | -0.307 | -0.139 | -0.033 |
| Income Tax Expense
| -0.205 | -0.261 | -0.384 | -0.282 | -0.254 | -0.336 | -0.189 | -0.622 | -0.542 | -0.16 | -0.178 | -0.274 |
| Net Income
| -0.488 | -0.767 | -0.231 | 0.349 | -0.787 | -5.959 | -2.083 | -2.965 | -2.964 | -1.914 | -0.972 | -0.339 |
| Net Income Ratio
| -0.04 | -0.069 | -0.022 | 0.036 | -0.088 | -0.658 | -0.232 | -0.392 | -0.417 | -0.283 | -0.118 | -0.033 |
| EPS
| -0.038 | -0.059 | -0.025 | 0.037 | -0.084 | -0.63 | -0.28 | -0.44 | -0.53 | -0.42 | -0.24 | -0.013 |
| EPS Diluted
| -0.038 | -0.059 | -0.025 | 0.037 | -0.084 | -0.63 | -0.28 | -0.44 | -0.53 | -0.42 | -0.24 | -0.013 |
| EBITDA
| 0.245 | -0.28 | 0.048 | 0.717 | 0.126 | 0.101 | -1.492 | -2.803 | -2.724 | -1.754 | -0.371 | -0.23 |
| EBITDA Ratio
| 0.02 | -0.025 | 0.005 | 0.074 | 0.014 | 0.011 | -0.166 | -0.371 | -0.383 | -0.259 | -0.045 | -0.023 |